Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-course versus standard-course antibiotics for catheter-associated urinary tract infection
NL-OMON26262Suspended
- Sponsor
- Amsterdam UMC, Department of Infectious Diseases
- Start
- Sep 2017
- Countries
- 1
01
Overview
Randomised, open-label trial in catheter-associated urinary tract infection (CAUTI) (2 arms), sponsored by Amsterdam UMC, Department of Infectious Diseases. Primary endpoint: Recurrence of symptomatic urinary tract infection during 90 days after randomization. Started Sep 2017; status: suspended.
02
Conditions
catheter-associated urinary tract infection (CAUTI)
Beyond the preview
Go deeper on NL-OMON26262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26262.